arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Health Catalyst, Inc.

HCAT
$1.73 ▼ -0.56 (-24.67%) at close
Technology ·Services-Computer Programming, Data Processing, Etc. ·USServices-Computer Programming, Data Processing, Etc.
35 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Health Catalyst, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $125.6M
Dividend Yield
Revenue Growth -10.9%
Op. Margin -150.5%
ROIC -28.9%
FCF / Share $0.25
Trailing P/E
Price / Book 0.9x
FCF Yield 14.5%
Debt / Equity 1.11
info Valuation on last close. End-of-day price, Aug 7, 2026.

35-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$70.76M
↓ -10.9%
Net Income Profit after all expenses
$-111.03M
↓ -367.6%
Operating Margin Operating profit as % of sales
-150.5%
↓ -30.6% 5th
FCF / Share Free cash flow per share
$0.25
↑ +2550.4%
Long-Term Debt Long-term obligations
$153.37M
— +0.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
11
Returns
12
Financial Health
38
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters